UBS Maintains a 'Buy' on Gevo, Inc. (GEVO); Court Orders Limits to Chemicals for Now

June 14, 2012 11:12 AM EDT
Get Alerts GEVO Hot Sheet
Price: $1.69 +4.32%

Rating Summary:
    10 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Buy' on Gevo, Inc. (NASDAQ: GEVO) price target of $13.00.

Yesterday morning, GEVO issued a public statement in reaction to a temporary order issued by the U.S. District Court of Delaware requesting that the company “maintain status quo” until the Court renders its decision on the pending request for a preliminary injunction.

“In light of our recent startup and Gevo’s ability to bring commercial scale isobutanol to market, we respect the judge’s decision to issue an order instructing Gevo to maintain the status quo. As the judge has not made a decision for or against the preliminary injunction to date, it’s understandable that she wants to make sure Gevo sticks to its current business plan. For Gevo, that means we continue to optimize Luverne operating parameters, continue engineering work and preparation for construction of Redfield and most importantly we sell our renewable isobutanol to Sasol and the U.S. Air Force.” -- Brett Lund, EVP & General Counsel for Gevo.

For an analyst ratings summary and ratings history on Gevo, Inc. click here. For more ratings news on Gevo, Inc. click here.

Shares of Gevo, Inc. closed at $5.75 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

UBS